Table 1 Clinical features of patients (n = 10)
Patient | ||
|---|---|---|
No | % | |
Sex | ||
Male | 5 | 50.0% |
Female | 5 | 50.0% |
Age (years) | ||
Range | 27–52 | |
Median | 43.5 | |
ECOG performance stage | ||
0–1 | 7 | 70.0% |
≥ 2 | 3 | 30.0% |
Ann Arbor clinical stage | ||
III | 2 | 20.0% |
IV | 8 | 80.0% |
LDH higher than ULN | 7 | 70.0% |
Disease type | ||
DLBCL | 10 | 100.0% |
Prior therapies | ||
Range3–10 | ||
Median | 9 | |
IPI | ||
0–1 | 0 | 0 |
2 | 4 | 40.0% |
3 | 5 | 50.0% |
4 | 1 | 10.0% |